Dr. Bear is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
705 Riley Hosp Dr # 3300 Fl 3
Indianapolis, IN 46202- Is this information wrong?
Education & Training
- Indiana University School of MedicineMSc, Clinical Research, 2008 - 2012
- Indiana University School of MedicineFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- Indiana University School of MedicineResidency, Pediatrics, 2004 - 2007
- Pennsylvania State University College of MedicineClass of 2004
Certifications & Licensure
- IN State Medical License 2005 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 8 citationsOutpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuro...Jaume Mora, Godfrey C Chan, Daniel A Morgenstern, Karsten Nysom, Melissa K Bear, Karen Tornøe, Brian H Kushner> ;Cancer Reports. 2023 Jan 1
- 20 citationsnextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer.Erika Hamilton, Javier Cortes, Ozgur Ozyilkan, Shin-Cheh Chen, Katarína Petráková, Aleksey Manikhas, Guy Jerusalem, Roberto Hegg, Jens Huober, Sonya C. Chapman, Yi Lu,...> ;Clinical Breast Cancer. 2021 Jun 1
- 1 citationsCorrection: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-positive Breast Cancer.Sara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, Thomas Bachelot, Peter Kabos, Ahmad Awada, Denise Yardley, Arlene Chan, Pierfranco Conte, Véronique Diéras, Nancy U Li...> ;Clinical Cancer Research. 2021 Mar 1
- Join now to see all
Journal Articles
- A Standardized autopsy procurement allow for the comprehensive study of DIPG biologyMadhuri Kambhampati,Jennifer P Perez,Sridevi Yadavilli, Amanda M. Saratsis,Ashley D. Hill, Cheng-Ying Ho, Eshini Panditharatna,Melissa Markel, Roger J. Packer,Javad N..., Oncotarget, 5/2015
Abstracts/Posters
- A phase 2 study of abemaciclib in patients with leptomeningeal metastases secondary to HR+, HER2- breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Bre...Tolaney SM, Sahebjam S, Le Rhun E, Lin NU, Markel Bear M, Yang Z, Chen Y, Anders CK, Proceedings of the 2018 San Antonio Breast Cancer Symposium;, 12/2018
- nextMONARCH 1: Phase 2 study of abemaciclib plus tamoxifen or abemaciclib alone in HR+, HER2- advanced breast cancer [abstract].Hamilton E, Cortes J, Dieras V, Ozyilkan O, Chen S-C, Petrakova K, Manikhas A, Jerusalem G, Hegg R, Lu Y, Bear MM, Johnston EL, Martin M, In: Proceedings of the 2018 San Antonio Breast Cancer Symposium;, 12/2018
- Examining Urinary Biomarkers of Cisplatin Nephrotoxicity in Children.Markel M, Ross J, Then J, Renbarger J., Pediatric Blood and Cancer., ASPHO, 2016
Hospital Affiliations
- Indiana University Health University HospitalIndianapolis, Indiana
- Indiana University Health North HospitalCarmel, Indiana
- Riley Hospital for Children at IU HealthIndianapolis, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: